Psychopharmacology in myasthenia gravis patients with focus on depression
Article
| IMSEAR
| ID: sea-211558
ABSTRACT
Myasthenia gravis is an autoimmune disease with a potential to disrupt brain function and cause depression as a result of the disease itself or treatment side effect. Some biological and psychological mechanisms have been proposed for the correlations between myasthenia gravis and depression. Depression might present in patients myasthenia gravis, and it might complicate the course of the disease. Adequate treatment might not only improve the depression but might also impact the myasthenia gravis in general.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS